Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.95
-0.1800-8.45%
Post-market: 1.970.0200+1.03%19:30 EDT
Volume:4.18M
Turnover:8.40M
Market Cap:72.98M
PE:-1.33
High:2.14
Open:2.13
Low:1.95
Close:2.13
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:0.53
T/O Rate:23.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.64
PE(LYR):-1.45

Loading ...

Jan 05, 2022

Major Issues Report

8-K - Current report
Dec 06, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 14, 2021

Major Issues Report

8-K - Current report
Sep 14, 2021

Major Issues Report

8-K - Current report
Sep 02, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 31, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 24, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 08, 2021

Major Issues Report

8-K - Current report
Jun 22, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 22, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 11, 2021

Major Issues Report

8-K - Current report
Jun 01, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 07, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2021

Major Issues Report

8-K/A [Amend] - Current report